EG24590A - Benzimidazole and pyridylimidazole derivative as ligands gabaa receptors - Google Patents

Benzimidazole and pyridylimidazole derivative as ligands gabaa receptors

Info

Publication number: EG24590A
Authority: EG; Egypt
Prior art keywords: benzimidazole; ligands; gabaa receptors; pyridylimidazole derivative; pyridylimidazole
Prior art date: 2000-12-21

Application number

EG20011360A

Other languages

English (en)

Inventor

Guiying Li

John M Peterson

Pamela Albaugh

Kevin S Currie

Guolin Cai

Linda M Gustavson

Kyungae Lee

Alan Hutchison

Vinod Singh

George Maynard

Jun Yuan

Xie Ling Hong

Manuka Ghosh

Nian Liu

George P Luke

Scott Mitchell

Martin P Allen

Spiros Liras

Original Assignee

Neurogen Corp

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-21

Filing date

2001-12-22

Publication date

2009-12-07

2001-12-22 Application filed by Neurogen Corp, Pfizer filed Critical Neurogen Corp

2009-12-07 Application granted granted Critical

2009-12-07 Publication of EG24590A publication Critical patent/EG24590A/xx

Links

HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 title 1
102000027484 GABAA receptors Human genes 0.000 title 1
108091008681 GABAA receptors Proteins 0.000 title 1
239000003446 ligand Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/08—Bridged systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

EG20011360A 2000-12-21 2001-12-22 Benzimidazole and pyridylimidazole derivative as ligands gabaa receptors EG24590A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US25749200P	2000-12-21	2000-12-21

Publications (1)

Publication Number	Publication Date
EG24590A true EG24590A (en)	2009-12-07

Family

ID=22976520

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EG20011360A EG24590A (en)	2000-12-21	2001-12-22	Benzimidazole and pyridylimidazole derivative as ligands gabaa receptors

Country Status (40)

Country	Link
US (4)	US6916819B2 (de)
EP (1)	EP1368342B3 (de)
JP (1)	JP2004536782A (de)
KR (1)	KR100854174B1 (de)
CN (1)	CN1553909A (de)
AP (1)	AP1503A (de)
AR (1)	AR035774A1 (de)
AT (1)	ATE304008T1 (de)
AU (2)	AU3276802A (de)
BG (1)	BG107899A (de)
BR (1)	BR0116385A (de)
CA (1)	CA2431592A1 (de)
CO (1)	CO5390086A1 (de)
CZ (1)	CZ20031676A3 (de)
DE (1)	DE60113302T2 (de)
EA (1)	EA007157B1 (de)
EC (1)	ECSP034656A (de)
EE (1)	EE05108B1 (de)
EG (1)	EG24590A (de)
ES (1)	ES2256325T3 (de)
HR (1)	HRP20030483A9 (de)
HU (1)	HUP0303849A3 (de)
IL (1)	IL156294A0 (de)
IS (1)	IS6855A (de)
MA (1)	MA26974A1 (de)
MX (1)	MXPA03005493A (de)
MY (1)	MY141733A (de)
NO (1)	NO326558B1 (de)
NZ (1)	NZ526330A (de)
OA (1)	OA12539A (de)
PA (1)	PA8535601A1 (de)
PE (1)	PE20020720A1 (de)
PL (1)	PL366243A1 (de)
SK (1)	SK7672003A3 (de)
TW (1)	TWI304402B (de)
UA (1)	UA75902C2 (de)
UY (1)	UY27095A1 (de)
WO (1)	WO2002050062A2 (de)
YU (1)	YU51703A (de)
ZA (1)	ZA200304544B (de)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI248936B (en) *	2001-03-21	2006-02-11	Merck Sharp & Dohme	Imidazo-pyrimidine derivatives as ligands for GABA receptors
IL159811A0 (en)	2001-07-13	2004-06-20	Neurogen Corp	Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands
US6906075B2 (en)	2002-01-10	2005-06-14	Neurogen Corp.	Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
US7160879B2 (en)	2002-01-10	2007-01-09	Neurogen Corporation	Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1H-benzoimidazole analogues
AU2003245259A1 (en)	2002-05-02	2003-11-17	Neurogen Corporation	Substituted imidazole derivatives: gabaa receptor ligands
JP2006515278A (ja)	2002-05-08	2006-05-25	ニューロジェンコーポレイション	置換イミダゾリルメチルピリジン及びピラジン誘導体並びにそれらのｇａｂａａ受容体リガンドとしての使用
US6916827B2 (en)	2002-05-17	2005-07-12	Neurogen Corporation	Substituted ring-fused imidazole derivative: GABAA receptors ligands
US20040063938A1 (en) *	2002-09-30	2004-04-01	Pfizer Inc	Process for preparing haloalkyl pyrimidines
CN100579579C (zh) *	2002-10-01	2010-01-13	诺华疫苗和诊断公司	抗癌及抗感染性疾病组合物及其使用方法
JP2006508102A (ja) *	2002-11-08	2006-03-09	ニューロジェン・コーポレイション	Ｇａｂａａ受容体のリガンドとしての４−イミダゾール−１−イルメチル−ピリミジン誘導体
US20060084682A1 (en) *	2002-12-13	2006-04-20	Heerding Dirk A	Thrombopoietin mimetics
US7169801B2 (en) *	2003-03-17	2007-01-30	Takeda San Diego, Inc.	Histone deacetylase inhibitors
SE0301699D0 (sv) *	2003-06-10	2003-06-10	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
EP1880998A1 (de) *	2003-07-25	2008-01-23	Neurogen Corporation	Imidazo-Pyrimide und Triazolo-Pyrimide: Benzodiazepin-Rezeptorliganden
CN100457756C (zh) *	2003-07-25	2009-02-04	神经能质公司	咪唑-嘧啶类及三唑-嘧啶类:苯并二氮平受体配体
AU2004261591A1 (en) *	2003-07-25	2005-02-10	Neurogen Corporation	Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands
US7781595B2 (en)	2003-09-22	2010-08-24	S*Bio Pte Ltd.	Benzimidazole derivatives: preparation and pharmaceutical applications
HUP0304101A3 (en) *	2003-12-22	2008-10-28	Sanofi Aventis	Pyrazole derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates
WO2005121132A1 (ja) *	2004-06-11	2005-12-22	Shionogi & Co., Ltd.	抗ｈｃｖ作用を有する縮合ヘテロ環化合物
US7534796B2 (en)	2005-02-18	2009-05-19	Wyeth	Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor
US7538113B2 (en)	2005-02-18	2009-05-26	Wyeth	4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7582634B2 (en)	2005-02-18	2009-09-01	Wyeth	7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7531542B2 (en)	2005-05-18	2009-05-12	Wyeth	Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
US7582636B2 (en)	2005-05-26	2009-09-01	Wyeth	Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor
KR101022082B1 (ko) *	2005-10-11	2011-03-17	에프. 호프만-라 로슈 아게	아이소옥사졸 유도체
CN101346372B (zh)	2005-12-23	2011-09-28	弗·哈夫曼-拉罗切有限公司	芳基-异唑-4-基-二唑衍生物
KR101121372B1 (ko)	2005-12-27	2012-04-12	에프. 호프만-라 로슈 아게	아릴-이속사졸-4-일-이미다졸 유도체
AU2007207053B2 (en)	2006-01-17	2012-05-24	F. Hoffmann-La Roche Ag	Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine useful for the treatment of Alzheimer's disease via GABA receptors
BRPI0711850A2 (pt)	2006-05-31	2011-12-13	Hoffmann La Roche	derivados de aril-4-etinil-isoxazol
TW200808772A (en) *	2006-06-13	2008-02-16	Astrazeneca Ab	Therapeutic compounds
WO2008016123A1 (en) *	2006-08-03	2008-02-07	Takeda Pharmaceutical Company Limited	GSK-3β INHIBITOR
WO2008051533A2 (en) *	2006-10-25	2008-05-02	Takeda Pharmaceutical Company Limited	Benzimidazole compounds
CA2690975A1 (en)	2007-06-22	2008-12-31	F. Hoffmann-La Roche Ag	Isoxazole-imidazole derivatives
TW200911803A (en) *	2007-07-16	2009-03-16	Organon Nv	6-phenyl-1H-imidazo [4,5-c] pyridine-4-carbonitrile derivatives
MX2010001630A (es) *	2007-08-10	2010-03-15	Cortex Pharma Inc	Amidas bicíclicas para mejorar las respuestas sinápticas glutamatergícas.
US7618973B2 (en)	2007-12-04	2009-11-17	Hoffmann-La Roche Inc.	Isoxazolo-pyrazine derivatives
US7943619B2 (en)	2007-12-04	2011-05-17	Hoffmann-La Roche Inc.	Isoxazolo-pyridazine derivatives
US7902201B2 (en)	2007-12-04	2011-03-08	Hoffmann-La Roche Inc.	Isoxazolo-pyrazine derivatives
TW201033201A (en)	2009-02-19	2010-09-16	Hoffmann La Roche	Isoxazole-isoxazole and isoxazole-isothiazole derivatives
US8389550B2 (en)	2009-02-25	2013-03-05	Hoffmann-La Roche Inc.	Isoxazoles / O-pyridines with ethyl and ethenyl linker
US8222246B2 (en)	2009-04-02	2012-07-17	Hoffmann-La Roche Inc.	Substituted isoxazoles
US20100280019A1 (en)	2009-04-30	2010-11-04	Roland Jakob-Roetne	Isoxazoles
CN102414204B (zh)	2009-05-05	2014-12-31	弗·哈夫曼-拉罗切有限公司	异噁唑-哒嗪衍生物
EP2427455B1 (de)	2009-05-05	2020-01-15	F.Hoffmann-La Roche Ag	Isoxazol-pyrazole derivate
SG175867A1 (en)	2009-05-05	2011-12-29	Hoffmann La Roche	Isoxazole-pyridine derivatives
US8178522B2 (en)	2009-05-05	2012-05-15	Hoffmann-La Roche Inc.	Thiazoles
KR101354416B1 (ko)	2009-05-07	2014-02-19	에프. 호프만-라 로슈 아게	감마-아미노부티르산 조절제로서 이속사졸-피리딘 유도체
RU2635662C2 (ru) *	2010-09-10	2017-11-15	Сионоги Энд Ко., Лтд.	Конденсированное с гетерокольцом имидазольное производное, обладающее активирующим амрк действием
EP3170813B1 (de)	2010-10-06	2018-12-12	GlaxoSmithKline LLC	Benzimidazol-derivate als pi3-kinase-hemmer
EP2640391B1 (de)	2010-11-15	2015-11-11	Agenebio, Inc.	Pyridazinderivate, zusammensetzungen und verfahren zur behandlung von kognitiven störungen
EP2677869B1 (de) *	2011-02-25	2017-11-08	Merck Sharp & Dohme Corp.	Neue cyclische azabenzimidazolderivate als antidiabetika
WO2012116440A1 (en) *	2011-03-03	2012-09-07	Zalicus Pharmaceuticals Ltd.	Benzimidazole inhibitors of the sodium channel
CN102653531B (zh) *	2011-03-04	2014-08-13	上海爱普植物科技有限公司	一种马索亚内酯的合成方法
CN103857661B (zh) *	2011-08-11	2016-11-16	拜耳知识产权有限责任公司	1,2,4‑三唑基取代的酮烯醇
US8785435B2 (en)	2011-10-20	2014-07-22	Hoffmann-La Roche Inc.	Solid forms
GB201119538D0 (en) *	2011-11-10	2011-12-21	Viral Ltd	Pharmaceutical compounds
HK1201270A1 (en)	2012-01-11	2015-08-28	Bayer Intellectual Property Gmbh	Tetrazol-5-yl- and triazol-5-yl-aryl compounds and use thereof as herbicides
US20150374705A1 (en)	2012-02-14	2015-12-31	Shanghai Institues for Biological Sciences	Substances for treatment or relief of pain
JP6197031B2 (ja)	2012-05-24	2017-09-13	セルゾームリミティッド	Ｔｙｋ２阻害剤としてのヘテロシクリルピリミジン類似体
JP6230344B2 (ja) *	2013-09-06	2017-11-15	株式会社東芝	蒸気タービンプラント
WO2015052178A1 (en)	2013-10-10	2015-04-16	Basf Se	1,2,5-oxadiazole compounds and their use as herbicides
WO2015052173A1 (en)	2013-10-10	2015-04-16	Basf Se	Tetrazole and triazole compounds and their use as herbicides
EP3083569B1 (de)	2013-12-20	2022-01-26	Agenebio, Inc.	Benzodiazepinderivate, zusammensetzungen und verfahren zur behandlung von kognitiven störungen
EP3099672A4 (de)	2014-01-31	2017-09-20	ONO Pharmaceutical Co., Ltd.	Kondensierte imidazolverbindungen
TWI675031B (zh) *	2014-02-17	2019-10-21	德商拜耳作物科學股份有限公司	作為殺蟲劑之2-(雜環)芳基-取代之稠合雙環雜環衍生物
ES2795748T3 (es) *	2014-07-31	2020-11-24	Pasteur Institut Korea	Derivados de 2-amino-bencimidazol como inhibidores de 5-lipoxigenasa y/o prostaglandina E sintasa para tratar enfermedades inflamatorias
DK3240785T3 (da)	2014-12-29	2021-09-27	Us Health	Småmolekylede hæmmere af laktasedehydrogenase og fremgangsmåder til brug deraf
UY36548A (es)	2015-02-05	2016-06-01	Bayer Cropscience Ag	Derivados heterocíclicos condensados bicíclicos sustituidos por 2-(het)arilo como pesticidas
UY36547A (es)	2015-02-05	2016-06-01	Bayer Cropscience Ag	Derivados heterocíclicos condensados bicíclicos sustituidos por 2-(het)arilo como pesticidas
EP3280716B1 (de)	2015-04-08	2020-02-12	Bayer CropScience AG	Imidazo[1,2-a]pyridin-2-yl-derivate als schädlingsbekämpfungsmittel und deren zwischenprodukte
IL256354B (en)	2015-06-19	2022-09-01	Agenebio Inc	Benzodiazepine derivatives, compositions, and uses thereof for treating cognitive impairment
CN107922396B (zh)	2015-07-20	2022-08-05	建新公司	集落刺激因子-1受体(csf-1r)抑制剂
EP3331870B1 (de)	2015-08-07	2021-06-16	Bayer CropScience Aktiengesellschaft	2-(het)aryl-substituierte kondensierte heterocyclen-derivate als schädlingsbekämpfungsmittel
PE20181198A1 (es)	2015-10-26	2018-07-23	Bayer Cropscience Ag	Derivados de heterociclos biciclicos condensados como agentes de control de plagas
WO2017093180A1 (de)	2015-12-01	2017-06-08	Bayer Cropscience Aktiengesellschaft	Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
WO2017144341A1 (de)	2016-02-23	2017-08-31	Bayer Cropscience Aktiengesellschaft	Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
WO2017157332A1 (zh) *	2016-03-18	2017-09-21	江苏恒瑞医药股份有限公司	芳香酰胺类衍生物、其制备方法及其在医药上的应用
WO2017174414A1 (de)	2016-04-05	2017-10-12	Bayer Cropscience Aktiengesellschaft	Naphthalin-derivate als schädlingsbekämpfungsmittel
AR108257A1 (es)	2016-05-02	2018-08-01	Mei Pharma Inc	Formas polimórficas de 3-[2-butil-1-(2-dietilamino-etil)-1h-bencimidazol-5-il]-n-hidroxi-acrilamida y usos de las mismas
EP3241830A1 (de)	2016-05-04	2017-11-08	Bayer CropScience Aktiengesellschaft	Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
MX2019000793A (es)	2016-07-19	2019-06-20	Bayer Cropscience Ag	Derivados de heterociclos biciclicos condensados como pesticidas.
KR102419244B1 (ko)	2016-08-15	2022-07-08	바이엘 크롭사이언스 악티엔게젤샤프트	해충 방제제로서의 축합 바이시클릭 헤테로사이클 유도체
EP3500568B1 (de)	2016-08-16	2020-09-23	Bayer CropScience Aktiengesellschaft	Verfahren zur herstellung von 2-(3,6-dihalopyridin-2-yl)-3h-imidazol[4,5-c]pyridinderivaten und verwandten verbindungen durch umsetzung des 3h-imidazol[4,5-c]pyridinderivats mit einer metallorganischen zink-amin base
EP3515921B1 (de)	2016-09-19	2021-10-27	Bayer CropScience Aktiengesellschaft	Pyrazolo[1,5-a]pyridin- derivative und ihre verwendung als schädlingsbekämpfungsmittel
KR102477315B1 (ko)	2016-10-06	2022-12-13	바이엘 크롭사이언스 악티엔게젤샤프트	해충 방제제로서의 2-(헤트)아릴-치환된 융합 비사이클릭 헤테로사이클 유도체
DK3548466T3 (da)	2016-12-01	2022-04-19	Syngenta Participations Ag	Fremgangsmåde til fremstilling af et mellemprodukt af pesticidaktive heterocykliske derivater med svovlindeholdende substituenter
BR112019012821A2 (pt)	2016-12-19	2019-11-26	Agenebio, Inc.	derivados de benzodiazepina, composições e métodos para o tratamento do comprometimento cognitivo
US20180170941A1 (en)	2016-12-19	2018-06-21	Agenebio, Inc.	Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
WO2018138050A1 (de)	2017-01-26	2018-08-02	Bayer Aktiengesellschaft	Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
TW201833107A (zh)	2017-02-06	2018-09-16	德商拜耳廠股份有限公司	作為殺蟲劑之經２－（雜）芳基取代的稠合雜環衍生物
BR112019022273B1 (pt)	2017-04-24	2023-04-11	Bayer Aktiengesellschaft	Derivados de heterociclo bicíclicos fundidos, seus usos, formulação agroquímica, método para controle de pragas animais, e plantas, partes de plantas e/ou sementes resistentes a pestes
CN117430622B (zh)	2017-10-04	2025-12-19	拜耳公司	用作害虫防治剂的杂环化合物的衍生物
EP3305786A3 (de)	2018-01-22	2018-07-25	Bayer CropScience Aktiengesellschaft	Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
JP2021514949A (ja)	2018-02-21	2021-06-17	バイエル・アクチエンゲゼルシヤフト	有害生物防除剤としての縮合二環式ヘテロ環誘導体
MX2020011061A (es)	2018-04-20	2020-11-06	Bayer Ag	Derivados de heterocicleno como agentes para el control de plagas.
MX2020013927A (es)	2018-06-19	2021-03-02	Agenebio Inc	Derivados de benzodiazepina, composiciones y metodos para tratar el deterioro cognitivo.
WO2020011086A1 (zh) *	2018-07-13	2020-01-16	四川科伦博泰生物医药股份有限公司	苯并二氮杂环类化合物、其制备方法及用途
EP3636645A1 (de)	2018-10-11	2020-04-15	Bayer Aktiengesellschaft	Verfahren zur herstellung schwefel-substituierter pyridinderivate
PY2011993A (es)	2019-02-26	2021-07-05	Bayer Ag	Derivados heterocíclos bicíclicos condensados como plaguicida
PY2012000A (es)	2019-02-26	2023-07-25	Bayer Ag	Derivados de heterociclos bicíclicos fusionados como pesticidas
AR119140A1 (es)	2019-06-13	2021-11-24	Pi Industries Ltd	Compuestos heterocíclicos fusionados y su uso como agentes de control de plagas
CN110407744A (zh) *	2019-08-13	2019-11-05	上海毕得医药科技有限公司	一种1-(4-氨基吡啶-2-基)乙酮的合成方法
CN111072681B (zh) *	2019-12-11	2020-11-06	郑州大学	一种靶向细胞膜表面gaba受体荧光探针及其制备方法和应用
JP2024500919A (ja)	2020-12-23	2024-01-10	ジェンザイム・コーポレーション	重水素化コロニー刺激因子－１受容体（ｃｓｆ－１ｒ）阻害剤
IL319072A (en)	2022-08-19	2025-04-01	Agenebio Inc	History of Benzazepine, Compositions and Methods for Treating Cognitive Impairment
CN115490646A (zh) *	2022-10-10	2022-12-20	安徽昊帆生物有限公司	3-硝基-1，2，4-三氮唑的制备方法
CN117486846B (zh) *	2023-10-31	2025-10-03	陕西科技大学	一种卡瓦内酯类化合物的全合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3150486A1 (de) *	1981-12-19	1983-08-25	Merck Patent Gmbh, 6100 Darmstadt	Imidazo(4,5-c)pyridine, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
KR100297445B1 (ko) *	1995-04-21	2001-10-25	페더 벨링	벤즈이미다졸화합물및감마-아미노부틸산수용체복합체의조절인자로서의그들의용도
GB9702524D0 (en) *	1997-02-07	1997-03-26	Merck Sharp & Dohme	Therapeutic agents
EP1011477A1 (de)	1997-03-04	2000-06-28	Medtronic Inc.	Bioprothetischer filmstreifen für chirurgisches klammergerät, sowie befestigungsverfahren dafür
CA2369557A1 (en) *	1999-04-02	2000-10-12	Neurogen Corporation	Aryl and heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of gabaa receptors
AU3931400A (en)	1999-04-02	2000-10-23	Neurogen Corporation	N-benzimidazolylmethyl- and n-indolylmethyl-benzamides and their use as crf modulators
JP2002541146A (ja)	1999-04-02	2002-12-03	ニューロゲンコーポレイション	アリールおよびヘテロアリール融合のアミノアルキル−イミダゾール誘導体および糖尿病薬としてのその使用
CA2369544A1 (en)	1999-04-02	2000-10-12	Robert W. Desimone	Aryl and heteroaryl fused aminoalkyl-imidazole derivatives:selective modulators of bradykinin b2 receptors
AU4218200A (en) *	1999-04-08	2000-10-23	University Of North Carolina At Chapel Hill, The	Polymerization of non-fluorinated monomers in carbon dioxide
BR0011823A (pt)	1999-06-22	2002-03-19	Neurosearch As	Derivado de benzimidazol, composto, composição farmacêutica, uso de um derivado de benzimidazol, e, método para tratamento, prevenção ou alìvio de uma doença ou de um distúrbio ou de uma condição de um corpo animal vivo
GB9921150D0 (en)	1999-09-07	1999-11-10	Merck Sharp & Dohme	Therapeutic agents
MXPA03002788A (es)	2000-09-29	2004-12-13	Neurogen Corp	Moduladores de receptor c5a de molecula pequena de alta afinidad.
JP2004510765A (ja)	2000-10-06	2004-04-08	ニューロジェン・コーポレーション	Ｃｒｆ受容体調節物質としてのベンズイミダゾールおよびインドール誘導体類
US7030150B2 (en)	2001-05-11	2006-04-18	Trimeris, Inc.	Benzimidazole compounds and antiviral uses thereof

2001
- 2001-12-20 PA PA20018535601A patent/PA8535601A1/es unknown
- 2001-12-21 EP EP01992307A patent/EP1368342B3/de not_active Expired - Lifetime
- 2001-12-21 EE EEP200300304A patent/EE05108B1/xx not_active IP Right Cessation
- 2001-12-21 BR BR0116385-0A patent/BR0116385A/pt not_active IP Right Cessation
- 2001-12-21 AR ARP010105998A patent/AR035774A1/es unknown
- 2001-12-21 AT AT01992307T patent/ATE304008T1/de not_active IP Right Cessation
- 2001-12-21 US US10/038,069 patent/US6916819B2/en not_active Expired - Fee Related
- 2001-12-21 UA UA2003065755A patent/UA75902C2/uk unknown
- 2001-12-21 PL PL01366243A patent/PL366243A1/xx not_active Application Discontinuation
- 2001-12-21 DE DE60113302T patent/DE60113302T2/de not_active Expired - Lifetime
- 2001-12-21 OA OA1200300157A patent/OA12539A/en unknown
- 2001-12-21 MX MXPA03005493A patent/MXPA03005493A/es active IP Right Grant
- 2001-12-21 JP JP2002551558A patent/JP2004536782A/ja active Pending
- 2001-12-21 AU AU3276802A patent/AU3276802A/xx active Pending
- 2001-12-21 AP APAP/P/2003/002818A patent/AP1503A/en active
- 2001-12-21 IL IL15629401A patent/IL156294A0/xx unknown
- 2001-12-21 MY MYPI20015821A patent/MY141733A/en unknown
- 2001-12-21 PE PE2001001296A patent/PE20020720A1/es not_active Application Discontinuation
- 2001-12-21 TW TW090131848A patent/TWI304402B/zh not_active IP Right Cessation
- 2001-12-21 KR KR1020037008480A patent/KR100854174B1/ko not_active Expired - Fee Related
- 2001-12-21 EA EA200300713A patent/EA007157B1/ru not_active IP Right Cessation
- 2001-12-21 YU YU51703A patent/YU51703A/sh unknown
- 2001-12-21 HU HU0303849A patent/HUP0303849A3/hu unknown
- 2001-12-21 CA CA002431592A patent/CA2431592A1/en not_active Abandoned
- 2001-12-21 CN CNA018223869A patent/CN1553909A/zh active Pending
- 2001-12-21 WO PCT/US2001/050038 patent/WO2002050062A2/en not_active Ceased
- 2001-12-21 ES ES01992307T patent/ES2256325T3/es not_active Expired - Lifetime
- 2001-12-21 CO CO01109589A patent/CO5390086A1/es not_active Application Discontinuation
- 2001-12-21 UY UY27095A patent/UY27095A1/es not_active Application Discontinuation
- 2001-12-21 AU AU2002232768A patent/AU2002232768B2/en not_active Ceased
- 2001-12-21 HR HR20030483A patent/HRP20030483A9/xx not_active Application Discontinuation
- 2001-12-21 SK SK767-2003A patent/SK7672003A3/sk unknown
- 2001-12-21 CZ CZ20031676A patent/CZ20031676A3/cs unknown
- 2001-12-21 NZ NZ526330A patent/NZ526330A/en active IP Right Revival
- 2001-12-22 EG EG20011360A patent/EG24590A/xx active
2003
- 2003-06-11 BG BG107899A patent/BG107899A/bg unknown
- 2003-06-11 ZA ZA2003/04544A patent/ZA200304544B/en unknown
- 2003-06-16 EC EC2003004656A patent/ECSP034656A/es unknown
- 2003-06-17 MA MA27199A patent/MA26974A1/fr unknown
- 2003-06-20 IS IS6855A patent/IS6855A/is unknown
- 2003-06-20 NO NO20032834A patent/NO326558B1/no not_active IP Right Cessation
2005
- 2005-07-12 US US11/179,458 patent/US7300945B2/en not_active Expired - Fee Related
2007
- 2007-11-19 US US11/942,480 patent/US7642267B2/en not_active Expired - Fee Related
2010
- 2010-01-05 US US12/652,435 patent/US20100267698A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AP2003002818A0 (en)	2003-06-30
KR20030071789A (ko)	2003-09-06
HRP20030483A9 (en)	2007-11-30
EE05108B1 (et)	2008-12-15
NO20032834L (no)	2003-08-08
OA12539A (en)	2006-06-05
EE200300304A (et)	2003-12-15
US7642267B2 (en)	2010-01-05
AU3276802A (en)	2002-07-01
AP1503A (en)	2005-12-24
DE60113302T2 (de)	2006-06-29
EA200300713A1 (ru)	2004-02-26
EP1368342B3 (de)	2010-12-01
CN1553909A (zh)	2004-12-08
HUP0303849A3 (en)	2009-08-28
YU51703A (sh)	2006-05-25
US7300945B2 (en)	2007-11-27
CA2431592A1 (en)	2002-06-27
NO20032834D0 (no)	2003-06-20
HUP0303849A2 (hu)	2004-03-01
US20100267698A1 (en)	2010-10-21
EP1368342A2 (de)	2003-12-10
ZA200304544B (en)	2005-05-25
PL366243A1 (en)	2005-01-24
EA007157B1 (ru)	2006-08-25
UA75902C2 (en)	2006-06-15
AR035774A1 (es)	2004-07-14
CZ20031676A3 (en)	2004-03-17
MA26974A1 (fr)	2004-12-20
ECSP034656A (es)	2003-10-28
ATE304008T1 (de)	2005-09-15
BG107899A (bg)	2004-08-31
HRP20030483A2 (en)	2005-04-30
US20080227793A1 (en)	2008-09-18
NO326558B1 (no)	2009-01-12
PE20020720A1 (es)	2002-08-12
US6916819B2 (en)	2005-07-12
US20060025425A1 (en)	2006-02-02
EP1368342B1 (de)	2005-09-07
KR100854174B1 (ko)	2008-08-26
PA8535601A1 (es)	2002-11-28
AU2002232768B2 (en)	2007-09-06
NZ526330A (en)	2006-09-29
SK7672003A3 (en)	2004-07-07
WO2002050062A3 (en)	2003-01-16
JP2004536782A (ja)	2004-12-09
TWI304402B (en)	2008-12-21
CO5390086A1 (es)	2004-04-30
BR0116385A (pt)	2005-12-13
DE60113302D1 (de)	2005-10-13
IL156294A0 (en)	2004-01-04
IS6855A (is)	2003-06-20
UY27095A1 (es)	2002-07-31
MY141733A (en)	2010-06-15
WO2002050062A2 (en)	2002-06-27
MXPA03005493A (es)	2004-04-20
US20030069257A1 (en)	2003-04-10
ES2256325T3 (es)	2006-07-16

Publication	Publication Date	Title
EG24590A (en)	2009-12-07	Benzimidazole and pyridylimidazole derivative as ligands gabaa receptors
AU2002232768A1 (en)	2002-09-05	Benzimidazole and pyridylimidazole derivatives as ligands for GABA receptors
AU2403802A (en)	2002-05-27	Benzimidazole derivatives
PL377215A1 (pl)	2006-01-23	Pochodne benzimidazolu oraz ich zastosowanie w charakterze ligandów receptora waniloidowego
IL199668A0 (en)	2011-08-01	New benzimidazole derivatives
EE200300049A (et)	2004-10-15	Imidasooli derivaadid
ATE254369T1 (de)	2003-11-15	Schnittstellenverflechtung
IL155443A0 (en)	2003-11-23	1- aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
ATE253067T1 (de)	2003-11-15	Diazabicyloderivate als nikotin-acetylcholin- rezeptorliganden
ATE360620T1 (de)	2007-05-15	Imidazolderivate
IL154618A0 (en)	2003-09-17	Quinolinone derivatives
NO20003902L (no)	2001-10-29	Sollysapparat
GB0002006D0 (en)	2000-03-22	Fixture
ATE327232T1 (de)	2006-06-15	Heterozyklylalkylindole oder -azaindole als 5- hydroxytryptamine-6 liganden
PL358584A1 (en)	2004-08-09	Cyclohexylamine derivative as subtype selective nmda receptor antagonists
EE200200204A (et)	2003-04-15	Asendatud bensimidasooli preparaat
IL155998A0 (en)	2003-12-23	Benzyl (idene) -lactams and their use as 5ht1-receptor ligands
AU4439801A (en)	2001-10-23	Pyrazolo-triazine derivatives as ligands for gaba receptors
AU2001270822A1 (en)	2002-01-30	Imidazolophthalazine derivatives as ligands for gabaa receptors
NO20022983D0 (no)	2002-06-20	Aminometyl-fenyl-cykloheksanonderivater
NO20021753D0 (no)	2002-04-12	Pentacykliske taksanforbindelser
IL150506A0 (en)	2003-02-12	New imidazole derivatives
AU2002235543A1 (en)	2002-03-04	Imidazolophthalazine derivatives as ligands for gabaa receptors
ZA200604857B (en)	2008-09-25	Novel 2-heteroaryl-substituted benzimidazole derivative
TW419048U (en)	2001-01-11	Filter network fixture